Purpose: The purpose of this study was to determine the prevalence of exerc
ise-induced bronchospasm (EIB) in collegiate cross-country runners using a
protocol involving an intense exercise challenge conducted in the same envi
ronment in which the athletes train and compete. Methods: One-hundred eight
een collegiate cross-country runners from the Los Angeles, California, metr
opolitan area participated in the study. All testing took place on a track
at the time and location of a normal practice session. The baseline peak ex
piratory flow rate (PEER) measurements (best of three) and preexercise hear
t rate were recorded, after which the athletes ran 2000 m on a track at 85%
of maximum heart rate. The postexercise heart rate was recorded and then P
EFR measurements at 2, 5, 10, and 30 min after exercise were recorded. The
athletes completed a 16-item questionnaire regarding asthma symptoms and he
alth history. Those athletes with a history of asthma and currently taking
medications for the asthma were then excluded from statistical analysis of
the questionnaire responses. A decrease in PEER of 15% was considered posit
ive for EIB. Results: Of the 114 athletes not currently taking medications
for asthma, at least 14% (16 athletes) were EIB positive. There was a poor
correlation between reported symptoms of asthma and testing positive for EI
B. Conclusion: This study demonstrates a high prevalence of EIB in collegia
te cross-country runners (at least 14%) and that reported symptoms are a po
or predictor of actual EIB.